Ilya Yuffa

SVP and Pres, Lilly Bio-Meds, Eli Lilly and Company.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jun 10, 2026Sold 2,500 shares at $1,150.77 of Eli Lilly and Company²
Feb 9, 2026Granted 4,163 shares at $1,044.67 of Eli Lilly and Company³
Feb 1, 2026Shares withheld for tax 1,512 shares at $1,037.15 of Eli Lilly and Company⁴
Feb 1, 2026Exercised options 3,394 shares of Eli Lilly and Company⁴
Aug 11, 2025Sold 1,250 shares at $627.01 of Eli Lilly and Company⁵
May 14, 2025Sold 1,250 shares at $749.24 of Eli Lilly and Company⁶
Feb 10, 2025Granted 7,123 shares at $868.88 of Eli Lilly and Company⁷
Feb 1, 2025Shares withheld for tax 1,434 shares at $811.08 of Eli Lilly and Company⁸
Feb 1, 2025Exercised options 3,269 shares of Eli Lilly and Company⁸
Feb 12, 2024Granted 4,790 shares at $737.26 of Eli Lilly and Company⁹
Feb 1, 2024Shares withheld for tax 1,664 shares at $645.61 of Eli Lilly and Company¹⁰
Feb 1, 2024Exercised options 3,702 shares of Eli Lilly and Company¹⁰
Feb 10, 2023Granted 1,350 shares at $345.12 of Eli Lilly and Company¹¹
Feb 16, 2022Sold 1,000 shares at $242.58 of Eli Lilly and Company¹²
Feb 15, 2022Sold 1,000 shares at $237.45 of Eli Lilly and Company¹²
Feb 9, 2022Granted 3,275 shares at $243.27 of Eli Lilly and Company¹³
Feb 8, 2021Granted 3,536 shares at $205.77 of Eli Lilly and Company¹⁴

The numbers on this page point here. Each one links to the record it came from.